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Evidence-Informed Policy?
Over the past decade, systematic re-
views and explicit evidence-based ap-
proaches have replaced expert opinion as
the basis for health policy [1]. In develop-
ing countries, the high disease burden
coupled with limited financial resources
for health requires governments, donors,
and the public to choose between com-
peting public health and clinical care
options, and increasingly they turn to
‘‘evidence’’ to inform these decisions.
Systematic reviews of the benefits and
harms of different policies and treatments
are one of the core sources of evidence,
providing concise summaries of the avail-
able research about effects [2]. Well-
conducted systematic reviews aim to
minimize bias in presenting and interpret-
ing results. This can arise due to inten-
tional or unintentional selective studies
inclusion, selective reporting, uncritical
reading of poorly conducted trials, and
incorrect inferences from the data across
studies [3]. Alongside evidence on effects,
decision making requires other informa-
tion including cost, disease burden, and
the acceptability and feasibility of the
policy options. Nevertheless, data on
effects is fundamental, because if some-
thing does not work, it will not impact on
health, and it is not cost-effective, irre-
spective of whether the drug is cheap or
expensive.
As members of the Cochrane Infectious
Diseases Group, we have, over the past
twenty years, seen steady growth in the
demand for systematic reviews to inform
international and national policy decisions
in infectious diseases. Our reviews have
been used by policy makers as they have
made recommendations to scale-up im-
pregnated mosquito nets [4], reintroduce
amodiaquine for malaria [5], change the
formula of ORS [6], and switch to
artesunate for severe malaria [7]. Howev-
er, not all our systematic reviews support
current policies; some identify research
gaps, and some cast doubt on the benefits
of the interventions. These gaps may
indicate further research is required before
these interventions can be recommended.
The most complicated policy situations
are those in which there is limited
evidence of public health benefit, yet
statements made by experts recommend
the policy. If indeed the expert opinion is
wrong, then the continued delivery of the
intervention may waste public resources,
or fail to bring about all of the promised
benefits. One such example of a current
debate is in routine deworming of all
schoolchildren in areas where intestinal
helminths occur. The Cochrane review, in
light of current guidelines, advocacy, and
policies, represents an area where assumed
benefit by expert panels is by no means
supported by quite a lot of available,
reliable research [8]. Whatever the out-
come of future recommendations from the
World Health Organization and others is,
what is important is that independent
syntheses by groups external to the
advocacy provide reliable summaries that
can be considered in decision making.
We are concerned that the neglected
tropical disease (NTD) academic commu-
nity has been slow to engage in evidence-
informed policy and debate, and may be
falling behind international best practice.
This is borne out of a concern that NTDs
are important diseases that need treat-
ments, but that international policies need
to stay in line with current international
expectations of evidence-informed policy
to avoid being discredited. To look for
evidence to confirm or refute these
concerns, we used appropriate systematic
methods (Text S1), and present our
interpretation of these data as a viewpoint
at the request of PLOS NTDs editors.
Influential Papers in NTD Policy
and the Evidence They Cite
To evaluate the use of evidence in
formulating current policies, we first
created a database of NTD citations by
searching MEDLINE for all articles con-
taining ‘‘neglected,’’ ‘‘neglected disease,’’
or ‘‘neglected tropical disease’’ in the title
or abstract, up to June 2012. From this
database, we used the Science Citation
Index to identify the ten most commonly
cited articles, conducted a brief content
analysis of these, and examined how they
referenced systematic reviews of effects
and randomized controlled trials to sup-
port the policies they advocated.
The complete findings of this analysis
are available in the supplementary mate-
rial published with this Viewpoint (see
Text S1). Of the ten articles, three focus
on disease burden and do not strongly
advocate for any particular intervention
[9–11]. The remaining seven promote
mass drug administration, with four drugs,
for between five and seven diseases [12–
18]. They cite between them a total of two
systematic reviews and 12 randomized
trials. Our interpretation of the analysis
is that:
N The top-cited advocacy articles have
assumed the effectiveness of mass drug
administration for all diseases encom-
passed;
N Citation of randomized controlled
trials is highly selective, and usually
does not relate to the main thrust of
the campaigns;
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N Citation of Cochrane reviews is non-
existent, although at least 12 relevant
reviews were available when the advo-
cacy articles were published.
What Evidence Is Available?
There are now 67 Cochrane reviews on
NTDs available in the Cochrane library.
While the effectiveness of some interven-
tions and programmes has been demon-
strated, the effectiveness of others is
unclear. For example:
N For soil-transmitted helminth infec-
tion, the drugs clear the infection and
improve health in infected individuals;
but routine mass deworming of chil-
dren probably doesn’t have strong
population benefits (42 included stud-
ies, 65,168 participants) [8], and rou-
tine deworming of pregnant women
has not been shown to improve
maternal or birth outcomes (three
included studies, 1,329 participants)
[19,20].
N For schistosomiasis, praziquantel ap-
pears to be effective at clearing infection
with S. mansoni (52 included studies,
10,269 participants) [21] and S. haema-
tobium (24 included studies, 6,315par-
ticipants) [22], but the relative benefits
and harms of mass population treat-
ments need to be reviewed.
N For filariasis, diethylcarbamazine has
been shown to reduce microfilariae in
individuals, and in communities
through medicated-salt programmes
(21 included studies, .100,000 partic-
ipants) [23]; but the current evidence
for albendazole does not demonstrate
an effect that is any different from
placebo (seven included studies, 6,997
participants) [24].
N For onchocerciasis, ivermectin has
been shown to be effective at prevent-
ing some forms of eye damage in
individuals and mass-treated popula-
tions, but a reduction in eventual
blindness has not been adequately
proven (four included studies, 5,399
participants) [25].
N For trachoma, antibiotics have been
shown to be effective at reducing
prevalence in community programmes
(14 included studies, 3,587 partici-
pants) [26], but face washing pro-
grammes have not (two included
studies, 2,560 participants) [27].
Our View
The ‘‘neglected tropical disease’’ move-
ment, like many areas of tropical medi-
cine, has a few powerful advocates driving
the international agenda. This advocacy-
based approach has been highly successful
at raising the profile of these important
tropical diseases and instrumental in the
development of policies and donor funds
for implementing disease control pro-
grammes.
However, we would now encourage the
academic NTD field to be reflective and
critical about the current policies, practice,
and impact. To date, there appears to have
been little use of systematic reviews and
only selective use of individual trials when
formulating these policies. The most cited
policy articles appear to assume the effec-
tiveness of mass drug administration, rather
than present a policy option supported by a
reliable evidence base. While some of these
policies concerned drugs already clearly
established as effective in individuals (such
as praziquantel for schistosomiasis) and in
communities (such as DEC-treated salt for
preventing filariasis), others remain less
clear, particularly when used in mass
administration programmes.
Our concern is that if we ignore this
mismatch, it could threaten the long-term
credibility of the programmes the advo-
cates are promoting. We would argue that
to be credible long term, to reassure
donors that money is being spent effec-
tively, and to ensure the best possible
outcomes for people living in endemic
areas, the field should be explicit and
transparent about the link between the
policies being advocated and a reliable
evidence base.
NTD advocacy started with pleas for
new drugs, and researchers need to
continue to develop, evaluate, and test
new interventions and treatment com-
binations through properly conducted
randomized controlled trials [28]. For
interpretation and integration of this
research into reliable health policies,
this necessarily requires their incor-
poration into independent, critical, and
reliable systematic reviews. We hope that
through dialogue and debate, a new
agenda of research priorities will emerge,
both for randomized controlled trials
evaluating drug efficacy in individual
diseases and for pragmatic implemen-
tation trials and health services research
to examine the impacts of these pro-
grammes on community health. Reviews
conducted by independent specialists in
collaboration with topic specialists
should be part of helping achieve global
consensus as the science in the field
moves forward.
Supporting Information
Text S1 A systematic appraisal of
use of evidence in the most highly
cited NTD literature: methods and
results. The authors created a database
of trials that wrote about ‘‘neglected
tropical diseases’’ through careful biblio-
metric analysis; they then took the ten
most cited articles and carried out a
content analysis. This examined what the
main message of the paper was; who the
authors were; and how they cited evi-
dence, particularly randomized controlled
trials and systematic reviews. This was
then compared with systematic reviews
that were available at the time of publica-
tion, and inferences drawn.
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